What's new

Human medicines European public assessment report (EPAR): Ztalmy, ganaxolone, Date of authorisation: 26/07/2023, Revision: 4, Status: Authorised

Human medicines European public assessment report (EPAR): Ztalmy, ganaxolone, Date of authorisation: 26/07/2023, Revision: 4, Status: Authorised

Jun 5, 2025 - 09:40
 0
Human medicines European public assessment report (EPAR): Ztalmy, ganaxolone, Date of authorisation: 26/07/2023, Revision: 4, Status: Authorised
Human medicines European public assessment report (EPAR): Ztalmy, ganaxolone, Date of authorisation: 26/07/2023, Revision: 4, Status: Authorised
Read More

Tags:

Previous Article

Human medicines European public assessment report (EPAR): Efmody, hydrocortisone...

Next Article

Human medicines European public assessment report (EPAR): Rivaroxaban Viatris (p...

Related Posts

Human medicines European public assessment report (EPAR): Poteligeo, mogamulizumab, Date of authorisation: 22/11/2018, Revision: 8, Status: Authorised

Human medicines European public assessment report (EPAR...

May 21, 2025  0

Human medicines European public assessment report (EPAR): Vipdomet, alogliptin,metformin, Date of authorisation: 18/09/2013, Revision: 13, Status: Authorised

Human medicines European public assessment report (EPAR...

May 19, 2025  0

EMEA-003049-PIP01-21-M01

EMEA-003049-PIP01-21-M01

May 15, 2025  0